Home
Issues
Search
HY
|
FR
|
EN
|
RU
Home
Search : St
Search
Result : 186
«
1
2
3
4
»
European registry of infectious endocarditis
The EURO-ENDO registry was initiated in 2018. Its objectives were to assess the epidemiological, clinical, bacteriological, and prognostic features of infective endocarditis. Initially only...
Gilbert Habib.
October 2024, page 51
Infectious endocarditis and cancers: results of the EURO-ENDO registry
Bernard Cosyns,
Gilbert Habib.
October 2024, page 55
Major hypereosinophilia associated with Fasciola hepatica distomatosis
Thierry Carmoi,
Magali Billhot,
Marc Aletti.
October 2024, page 60
Sweeteners: recent recommendations for health
Intense sweeteners are compounds with a higher sweetening power than sugar. Their use has grown in industrial products and at home to reduce sugar intake, which is associated to health risks. In...
Mélanie Deschasaux-Tanguy,
Bernard Srour,
Mathilde Touvier.
October 2024, page 66
Sargassum seaweed assaults the French West Indies
Since 2011, Martinique and the islands of Guadeloupe have been affected by repeated groundings, culminating in an exceptional wave in 2018. While the sargassum ( Sargassum natans and S. fluitans )...
Dabor Resiere,
Jonathan Florentin,
Rémi Nevière.
October 2024, page 71
Renal colic management
Renal colic is a common reason for consultation or emergency room visit. In most of the cases, it is caused by the migration of a urinary calculus and the resulting ureteral obstruction. In 2022...
Gauthier Raynal,
Christophe Alméras.
October 2024, page 80
Bipolar disorder in adolescents and adults
Christophe Lançon.
October 2024, page 87
Bipolar depression, suicide and the prescription of antidepressants
Christophe Lançon.
October 2024, page 94
Nutri-Score: when economic lobbies accuse academic researchers of a conflict of interest with... science!
Serge Hercberg,
Pilar Galan,
Mélanie Deschasaux-Tanguy,
Mathilde Touvier.
December 2024, page 6
Iconodiagnosis, the art of semiology
Philippe Charlier.
December 2024, page 10
Antimicrobial resistance in human and veterinary medicine: where are we?
In both human and veterinary medicine, the evolution of antimicrobial resistance is worrying for some antibiotics or bacterial species, but less for others. In humans and animals, the picture for...
Laurence Armand-Lefèvre,
Jean-Yves Madec.
December 2024, page 14
Risk of acquiring antibiotic-resistant bacteria and travel
The continuing expansion of international tourism increases the opportunities of contact with diverse epidemiological environments, leading to both a risk of bacterial acquisition or infection for...
Paul-Henri Consigny,
Laurence Armand-Lefèvre.
December 2024, page 20
Shortened antimicrobial therapy duration
Antibiotic treatment durations represent an important field of current clinical research. Indeed, shortening antibiotic duration during bacterial pathologies has several advantages: reducing the...
Aurélien Dinh,
Bernard Castan.
December 2024, page 26
Hospital antimicrobial stewardship
Hospital antimicrobial stewardship programs have been thought to preserve the efficacy of antimicrobials for the treatment of human and animal bacterial infections. They must apply for every...
Philippe Lesprit,
Patricia Pavese.
December 2024, page 34
How to read new antimicrobial susceptibility testing results?
Antimicrobial susceptibility testing (AST) results (formerly 'susceptible', 'intermediate' and 'resistant') are now expressed with the new susceptibility categories 'susceptible, standard dosing...
Frédéric Schramm,
Raphaël Lepeule.
December 2024, page 40
Phage therapy: where do we stand?
Bacteriophages, discovered at the beginning of the 20th century by Félix d'Hérelle, are viruses that infect and destroy bacteria. Unlike antibiotics, phages are specific to a given bacterial...
Alexandre Bleibtreu,
Sylvain Diamantis.
December 2024, page 46
New challenge in antibacterial treatments: 10 key messages
Pierre Tattevin.
December 2024, page 51
Women's particular pulmonary susceptibility to tobacco: the example of COPD
Women are more susceptible to the harmful effects of smoking than men, even with moderate exposure, and this vulnerability begins in childhood. The prevalence of smoking has even increased, in...
Gérard Peiffer,
Michel Underner,
Jean Perriot,
Chantal Raherison-Semjen.
December 2024, page 64
Fractures in children: epidemiological, diagnostic and therapeutic features
Mathilde Gaume,
Clélia Thouement,
Raphaël Vialle,
Manon Bachy-Razzouk.
December 2024, page 75
A history of French psychiatry
Cécilia De Varine,
Mathis Farcy.
December 2024, page 84
Recent advances in the treatment of paroxystic nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder ofhematopoietic stem cells, characterized by increased sensitivity to the lytic action of complement, corpuscular hemolytic...
Éléonore Kaphan,
Régis Peffault de Latour.
March 2025, page 6
When and how should a stool blood test be prescribed?
Bernard Denis,
Lionel Tabard,
Christelle Guillon,
Julien L’hirondel,
Callum G Fraser.
March 2025, page 18
Systemic juvenile idiopathic arthritis. Pediatric-onset Still’s disease
Still’s disease starts in most cases in childhood, and is called systemic juvenile idiopathic arthtritis when its onset is before the age of 16 years. However, there is a continuum with adult-onset...
Pierre Quartier.
March 2025, page 26
Non systemic forms of juvenile idiopathic arthristis
Juvenile idiopathic arthritis (JIA) is a group of diseases defined by the presence of arthritis of more than 6 weeks duration in patients aged less than 16 years after eliminating differential...
Arthur Felix,
Cécile Dumaine,
Ulrich Meinzer.
March 2025, page 33
Biotherapies for juvenile idiopathic arthristis
The introduction of biotherapies has dramatically changed the care and evolution of children with juvenile idiopathic arthritis. These biotherapies, directed against tumor necrosis factor (TNF)...
Florence A Aeschlimann,
Pierre Quartier.
March 2025, page 42
Zinner syndrome
Zakaria Haddadi,
Siham Bhallil,
Siham Nasri,
Imane Kamaoui,
Imane Skiker.
March 2025, page 58
Zosteriform skin metastases
Youssef Almheirat,
Sara Bensalem,
Houda Talbi,
Nassiba Zarrouki,
Siham Dikhaye,
Nada Zizi.
March 2025, page 59
Prion diseases
Prion diseases or subacute transmissible spongiform encephalopathies (TSE) are neurodegenerative diseases. The agent responsible for the disease and its transmission is a protein with an abnormal...
Jean-Philippe Brandel.
March 2025, page 65
Pregnancy and post-partum mental disorders
Thomas Le Nerzé,
Marine Le Floch,
Philippe Gillard,
Katell Faure,
Philippe Descamps,
Philippe Duverger,
Élise Riquin.
March 2025, page 83
Marcel Proust and doctors
Jacques Rouëssé.
March 2025, page 92
Should students be trained in general culture to develop a more humanistic approach to medicine?
Alain C Masquelet,
Jean-François Allilaire.
June 2025, page 15
Chronic coccygodynia
Chronic coccygodynia is defined as pain in the c occyx which has been present for more than six months and which is aggravated by sitting down and/or rising. Although the diagnosis is primarily...
Thibault Riant,
Cristina Graur.
June 2025, page 45
Irritable bowel syndrome
Irritable bowel syndrome (IBS) is a common functional digestive disorder affecting 4 to 10% of the population, with a female gender predominance. Although it is a benign disease, it can sometimes...
Jean-Marc Sabaté.
June 2025, page 48
Vulvodynias
Vulvodynia is a chronic pain. The distinction between so-called "provoked" vulvodynia and "spontaneous" vulvodynia allows a diagnostic and therapeutic orientation. "Provoked" vulvodynia responds to...
Éric Bautrant.
June 2025, page 55
Severe dysmenorrhea and endometriosis
Severe dysmenorrhoea, or grade 3 dysmenorrhoea according to the Andersch and Millson classification, is present in the vast majority of patients suffering from endometriosis from the first...
Éric Bautrant,
Chloé Lacoste,
Delphine Lhuillery.
June 2025, page 68
Neurofibromatosis type 1: recent advances
Neurofibromatosis type 1 (NF1) has been the subject of extensive research over the past decade, conducted by both French and international research groups. This work has led to significant...
Laura Fertitta,
Pierre Wolkenstein.
June 2025, page 83
«
1
2
3
4
»
